IPO registrations (S-1, F-1) · Registrants

Sonoma Pharmaceuticals, Inc.

SEC CIK
1367083 · filings on EDGAR ↗
Former names
Oculus Innovative Sciences, Inc. (2002–2016)
Registration
Form S-1, first filed 2006-07-03, last 2026-04-23; 8 initial registrations, 20 amendments
Outcome
Final prospectus filed 2007-01-26; declared effective 2007-01-24
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
5445 CONESTOGA COURT, SUITE 150, Boulder, CO 80301
EIN
68-0423298
Ticker
SNOA (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Sonoma Pharmaceuticals, Inc. on the corporate pages

Filings 49

FiledFormWhat it isName as filedEDGAR
2006-07-03S-1S-1 (registration)Oculus Innovative Sciences, Inc.0000950134-06-012612 ↗
2006-09-18S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-06-017848 ↗
2006-11-13S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-06-021230 ↗
2006-12-01S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000891618-06-000489 ↗
2006-12-18S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-06-023267 ↗
2006-12-20S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-06-023485 ↗
2007-01-03S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-07-000071 ↗
2007-01-08S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-07-000249 ↗
2007-01-24EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-07-000280 ↗
2007-01-26424B4424B4 (final prospectus)Oculus Innovative Sciences, Inc.0000950134-07-001360 ↗
2007-08-30S-1S-1 (registration)Oculus Innovative Sciences, Inc.0000891618-07-000530 ↗
2007-09-12EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-07-003649 ↗
2008-02-26EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-08-000657 ↗
2009-03-09S-1S-1 (registration)Oculus Innovative Sciences, Inc.0000950134-09-004751 ↗
2009-03-24S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950134-09-005959 ↗
2009-03-26EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-09-000730 ↗
2009-04-10S-1S-1 (registration)Oculus Innovative Sciences, Inc.0000950134-09-007341 ↗
2009-05-22S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000891618-09-000185 ↗
2009-06-17S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950123-09-014533 ↗
2009-07-09S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950123-09-021281 ↗
2009-07-21S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0000950123-09-023694 ↗
2009-07-24EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-09-002037 ↗
2009-07-28S-1MEFS-1MEF (added securities)Oculus Innovative Sciences, Inc.0000950123-09-026425 ↗
2009-09-03EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-09-002452 ↗
2011-05-03EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-11-001373 ↗
2011-12-02EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-11-003446 ↗
2014-07-21EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-14-002178 ↗
2014-11-21S-1S-1 (registration)Oculus Innovative Sciences, Inc.0001019687-14-004450 ↗
2015-01-07S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0001019687-15-000099 ↗
2015-01-13S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0001019687-15-000167 ↗
2015-01-16S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0001019687-15-000215 ↗
2015-01-20S-1/AS-1/A (amendment)Oculus Innovative Sciences, Inc.0001019687-15-000253 ↗
2015-01-20EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-15-000146 ↗
2015-08-06EFFECTEFFECT (declared effective)Oculus Innovative Sciences, Inc.9999999995-15-002213 ↗
2017-11-27EFFECTEFFECT (declared effective)Sonoma Pharmaceuticals, Inc.9999999995-17-003064 ↗
2018-10-12S-1S-1 (registration)Sonoma Pharmaceuticals, Inc.0001683168-18-003037 ↗
2018-11-07S-1/AS-1/A (amendment)Sonoma Pharmaceuticals, Inc.0001683168-18-003262 ↗
2018-11-16S-1/AS-1/A (amendment)Sonoma Pharmaceuticals, Inc.0001683168-18-003469 ↗
2018-11-16EFFECTEFFECT (declared effective)Sonoma Pharmaceuticals, Inc.9999999995-18-002915 ↗
2020-12-22EFFECTEFFECT (declared effective)Sonoma Pharmaceuticals, Inc.9999999995-20-003625 ↗
2023-09-19S-1S-1 (registration)Sonoma Pharmaceuticals, Inc.0001683168-23-006550 ↗
2023-10-13S-1/AS-1/A (amendment)Sonoma Pharmaceuticals, Inc.0001683168-23-007167 ↗
2023-10-26EFFECTEFFECT (declared effective)Sonoma Pharmaceuticals, Inc.9999999995-23-003093 ↗
2023-10-30424B4424B4 (final prospectus)Sonoma Pharmaceuticals, Inc.0001683168-23-007475 ↗
2023-11-20EFFECTEFFECT (declared effective)Sonoma Pharmaceuticals, Inc.9999999995-23-003391 ↗
2026-04-17S-1S-1 (registration)Sonoma Pharmaceuticals, Inc.0001683168-26-003052 ↗
2026-04-23S-1/AS-1/A (amendment)Sonoma Pharmaceuticals, Inc.0001683168-26-003139 ↗
2026-04-23EFFECTEFFECT (declared effective)Sonoma Pharmaceuticals, Inc.9999999995-26-001319 ↗
2026-04-27424B4424B4 (final prospectus)Sonoma Pharmaceuticals, Inc.0001683168-26-003212 ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Akao AkihisaDirector22007
Alimi HojabrDirector,OfficerCEO, President; Chief Executive Officer; President & CEO132007–2012
Brown Edward MDirector22007
Burlingame RobertDirector102007–2010
Conley Richard KDirector202007–2013
French Gregory MDirector; Director,OfficerChief Operating Officer222007–2013
Miller Robert EOfficer; OtherChief Financial Officer262007–2019
Schutz James JDirector,Officer; Officer; OtherChief Executive Officer; Chief Operating Officer; Vice President322007–2019
Thornton BruceOfficerChief Operating Officer; COO; Executive Vice President; Executive VP and COO; Executive VP & COO; Vice President102007–2025
Wokasch MichaelOfficerChief Operating Officer22007
Birnbaum Jay EDirector392007–2026
Redhair DanaOfficerVice President22007
Alton Gregg HDirector102008–2012person page Fuzzy
Carpenter MichelleOfficerVP of Regulatory and Quality22008
Harish SameerOther22013
MCLAUGHLIN JOHNDirector292013–2026
Harrison Russell JosephDirector182014–2018
BARBARI SHARON SURREYDirector172014–2018
Northey Robert AllenOfficerExec. VP of Res & Development; Exec. VP of Res & Devlpment; Exe. VP of Research and Dev.42015–2017
Umscheid MarcOfficerChief Strategy/Mkt Officer62017
Weigerstorfer PhilippeDirector62018–2026
Sandford Frederick JDirector,OfficerCEO and Interim CFO22018–2019
Dal Poggetto JohnOfficerChief Financial Officer; Controller102019–2026
Trombly Amy MossOfficerChief Executive Officer; Interim CEO122019–2026
Edwards Robert GrantOfficerChief Financial Officer22020
DVONCH JEROME JOfficerChief Financial Officer; Interim CFO102020–2026
White Chad NormanOfficerChief Financial Officer; Interim CFO22022
Jacoby VanessaDirector22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.